PUBLISHER: The Business Research Company | PRODUCT CODE: 2077805
PUBLISHER: The Business Research Company | PRODUCT CODE: 2077805
Mastitis control products are treatments and solutions used to prevent, identify, and manage mastitis, an inflammatory disease of the udder that commonly affects dairy animals. These include disinfectants, teat dips, antibiotics, and diagnostic tools that help ensure udder hygiene and lower infection risk. They contribute to better milk quality, improved animal health, and enhanced productivity in dairy farming.
The primary product types of mastitis control products include antibiotics, vaccines, disinfectants, teat sealants, diagnostic kits, and other variants. Antibiotics refer to antimicrobial agents used to treat bacterial infections in the mammary glands of dairy animals. These products are utilized across animal types including dairy cattle, sheep, goats, and other species, and are administered through topical, intramammary, and systemic routes. They are distributed through veterinary hospitals and clinics, retail pharmacies, online pharmacies, and other channels, and are used by end users including dairy farms, veterinary clinics, animal health laboratories, and research institutes.
Tariffs are impacting the mastitis control products market by increasing the cost of imported veterinary pharmaceuticals, diagnostic kits, disinfectants, and udder health management solutions, which raises operational costs for dairy farms and veterinary suppliers. This is especially affecting import-dependent regions such as Asia-Pacific and Latin America, where access to advanced animal health products becomes more costly and less stable. Segments like antibiotics and diagnostic kits are most affected due to reliance on global pharmaceutical supply chains and specialized raw material sourcing. Dairy farms and veterinary clinics are facing higher treatment and prevention expenses, which may slow the adoption of advanced mastitis control solutions. However, tariffs are also encouraging local production of veterinary medicines, expansion of regional dairy health manufacturing, and increased investment in alternative natural and probiotic-based solutions, supporting stronger long-term market resilience.
The mastitis control products market research report is one of a series of new reports from The Business Research Company that provides mastitis control products market statistics, including mastitis control products industry global market size, regional shares, competitors with a mastitis control products market share, detailed mastitis control products market segments, market trends and opportunities, and any further data you may need to thrive in the mastitis control products industry. This mastitis control products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mastitis control products market size has grown strongly in recent years. It will grow from $2.01 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising prevalence of mastitis in dairy cattle populations, increasing demand for high quality milk production, growth of veterinary healthcare infrastructure, expansion of commercial dairy farming operations, traditional reliance on antibiotics for infection control.
The mastitis control products market size is expected to see strong growth in the next few years. It will grow to $2.65 billion by 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising shift toward antibiotic free dairy production systems, increasing adoption of rapid diagnostic and preventive care solutions, growing demand for organic and residue free milk products, expansion of smart dairy farm monitoring technologies, increasing focus on animal welfare and sustainable livestock management practices. Major trends in the forecast period include data driven mastitis early detection and monitoring systems, antibiotic free and probiotic based udder health management solutions, sustainable and residue free dairy hygiene product development, automated milking hygiene and udder disinfection systems, rapid on farm diagnostic testing kits for mastitis detection.
The rising dairy production demand is anticipated to propel the growth of the mastitis control products market coming years. Dairy production refers to the process of producing milk and milk-based products from domesticated animals such as cows, buffaloes, goats, and sheep. The rise in dairy production is driven by increasing consumer demand for milk and dairy products, as growing populations and changing dietary preferences boost consumption. Mastitis control products help dairy production by preventing and treating udder infections, ensuring healthier cows, higher milk yield, and improved milk quality. For instance, in January 2026, according to the Bullvine, a Canada-based online community and information source for dairy breeding professionals, US milk production reached approximately 234.3 billion pounds, reflecting a 1.4% increase compared to 2025. Therefore, the rising dairy production demand is expected to drive the growth of the mastitis control products market.
Leading companies operating in the mastitis control products market are focusing on developing advanced solutions, such as rapid on-farm diagnostics, to enhance detection accuracy, reduce unnecessary antimicrobial use, and improve herd health management. Rapid on-farm diagnostics refers to quick, on-site tests that detect mastitis in dairy cows, enabling immediate treatment decisions. For example, in August 2023, Zoetis, a US-based animal health company, launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic that uses a simple flow dipstick test to detect Gram-positive mastitis within eight hours. The solution allows farmers and veterinarians to identify affected cows before the next milking, enabling targeted antimicrobial therapy, reducing unnecessary treatments, and supporting responsible antibiotic use.
In September 2024, Zoetis, a US-based provider of a comprehensive portfolio of mastitis control products, diagnostics, and vaccines designed for both lactating and dry cows, entered into a partnership with Danone. Through this partnership, Zoetis and Danone seek to improve dairy herd health and sustainability by applying genetics and farm management practices to prevent infections and encourage healthier cows, thereby supporting the goals of Mastitis Control Products. Danone is a France-based developer of science-based products aimed at controlling and reducing the incidence of mastitis in breastfeeding mothers.
Major companies operating in the mastitis control products market are Merck & Co, Boehringer Ingelheim, Ecolab Inc., Zoetis Inc., GEA Group AG, Elanco Animal Health, IDEXX Laboratories, Ceva Sante Animale, Virbac S. A., DeLaval Holding AB, Phibro Animal Health Corporation, Neogen Corporation, Vetoquinol, Norbrook Laboratories, Milkrite InterPuls, BouMatic LLC, Dairymaster, Bioveta a. s., Afimilk Ltd., ImmuCell Corporation
North America was the dominating region in the mastitis control products market in 2025. Asia Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the mastitis control products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the mastitis control products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mastitis control products market consists of sales of intramammary antibiotic infusion tubes, intramammary antibiotic infusion tubes, on-farm diagnostic test kits, and udder hygiene sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mastitis Control Products Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses mastitis control products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for mastitis control products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mastitis control products market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.